Evidence map›Paper›PMID 26113983›Full record

ArticleBMJ open diabetes research & care2015

Recommendations for management of diabetes during Ramadan: update 2015.

Mahmoud Ibrahim, Megahed Abu Al Magd, Firas A Annabi, Samir Assaad-Khalil, Ebtesam M Ba-Essa, Ibtihal Fahdil, Sehnaz Karadeniz, Terry Meriden, Aly A Misha'l, Paolo Pozzilli and 6 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ open diabetes research & care, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 5 pooled it
10.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 5 syntheses or guidelines pooled it, 180 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Diabetes among Muslims during Ramadan: A narrative review.World journal of clinical cases · 2023
    Review
  14. Article
  15. Article
  16. Review
  17. Observational
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 13 institutions in 8 countries.

Mahmoud IbrahimEDC, Center for Diabetes Education , McDonough, Georgia , USA.
Megahed Abu Al MagdDepartment of Internal Medicine , Mansura University , Mansura , Egypt.
Firas A AnnabiIslamic Hospital , Amman , Jordan.
Samir Assaad-KhalilDepartment of Internal Medicine, Unit of Diabetes & Metabolism , Alexandria Faculty of Medicine , Alexandria , Egypt.
Ebtesam M Ba-EssaDammam Medical Complex , Dammam , Saudi Arabia.
Ibtihal FahdilEastern Mediterranean Office of the World Health Organization , Cairo , Egypt.
Sehnaz KaradenizFlorence Nightingale Istanbul Hospital , Istanbul , Turkey.
Terry MeridenDivision of Endocrinology , University of IL , Chicago, Illinois , USA.
Aly A Misha'lIslamic Hospital , Amman , Jordan.
Paolo PozzilliDepartment of Endocrinology and Metabolism , University Campus Bio Medico , Rome , Italy.
Samad SheraDiabetic Association of Pakistan , Karachi , Pakistan.
Abraham ThomasNYU Lutheran , Brooklyn, New York , USA.
Suhad BahijriSaudi Diabetes Group , King Abdul Aziz University , Jeddah , Saudi Arabia.
Jaakko TuomilehtoNational Institute for Health and Welfare , Helsinki , Finland.
Temel YilmazDivision of Endocrinology and Metabolism, Department of Internal Medicine , Istanbul University , Istanbul , Turkey.
Guillermo E UmpierrezEmory University School of Medicine , Atlanta, Georgia , USA.
Islamic Hospital · JOAlexandria University · EGBaqai Institute of Diabetology and Endocrinology · PKDammam Central Hospital · SAEmory University · USFinnish Institute for Health and Welfare · FIIstanbul Florence Nightingale Hospital · TRIstanbul University · TRLutheran Medical Center · USMansoura University · EGUniversità Campus Bio-Medico · ITUniversity of Illinois Chicago · USWorld Health Organization Regional Office for the Eastern Mediterranean · EG

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025008 · NCRR · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2007 to 2011
$29.0M
Research BaseP30DK092926 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MARY ELLEN MICHELE HEISLER, ADESUWA B OLOMU · 2011 to 2026
$10.0M
NCRR NIH HHS UL1 RR025008NIDDK NIH HHS P30 DK092926World Health Organization 001
6 · The paper itself

Abstract

Since the first ADA working group report on the recommendations for management of diabetes during Ramadan in 2005 and our update in 2010, we received many inquiries asking for regular updates on information regarding education, nutritional habits and new oral and injectable agents that may be useful for the management of patients with diabetes during Ramadan. Patients can be stratified into their risk of hypoglycemia and/or complications prior to the start of the fasting period of Ramadan. Those at high risk of hypoglycemia and with multiple diabetic complications should be advised against prolonged fasting. Even in the lower hypoglycemia risk group, adverse effects may still occur. In order to minimize adverse side effects during fasting in patients with diabetes and improve or maintain glucose control, education and discussion of glucose monitoring and treatment regimens should occur several weeks prior to Ramadan. Agents such as metformin, thiazolidinediones and dipeptidyl peptidase-4 inhibitors appear to be safe and do not need dose adjustment. Most sulfonylureas may not be used safely during Ramadan except with extreme caution; besides, older agents, such as chlorpropamide or glyburide, should not be used. Reduction of the dosage of sulfonylurea is needed depending on the degree of control prior to fasting. Misconceptions and local habits should be addressed and dealt with in any educational intervention and therapeutic planning with patients with diabetes. In this regard, efforts are still needed for controlled prospective studies in the field of efficacy and safety of the different interventions during the Ramadan Fast.

Indexed as

A1CDietary BehaviorEducation and Behavioral Interventions

Identifiers

PMID26113983
PMCPMC4477152
OpenAlexW2159930162

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.